Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch...
11 Vote(s)
September 2, 2010
Naurex’s Novel Antidepressant GLYX-13 Recognized As One Of Windhover’s Top 10 Neuroscience Projects To Watch
Comments Off
May 21, 2010
‘I didn’t know what was wrong’: Physicians should help patients with depression name their problem, experts urge
To improve recognition and treatment of depression, primary care physicians should do three things: help their patients name their distress, provide explanations for the depression that conform to patients' experiences and reduce blame and stigma, according to new recommendations.
12 Vote(s)
12 Vote(s)
Comments Off
February 6, 2010
Behavioral treatment of depression for individuals with substance use disorders
by Michael D. Anestis, M.S. I had actually planned to write about a different topic today, but an interaction this morning led me to shift gears. A few hours ago, I attended a seminar led by Carl Lejuez of the...
20 Vote(s)
20 Vote(s)
Comments Off
January 7, 2010
Antidepressant medications versus placebos: The impact of depression severity
by Michael D. Anestis, M.S. In a number of past PBB articles, we have discussed the mountains of research supporting the efficacy and effectiveness of antidepressant medications in the treatment of depression. Within the past 24 hours, both Thomas Joiner...
10 Vote(s)
10 Vote(s)
Comments Off
December 23, 2009
November 7, 2009
New TMS Clinic At Rush University Medical Center Offers Non-Invasive Treatment For Major Depression
Rush University Medical Center has opened the Transcranial Magnetic Stimulation (TMS) Clinic to offer patients suffering from major depression a safe, effective, non-drug treatment. TMS therapy is the first FDA-approved, non-invasive antidepressant device-based treatment clinically proven for treatment of depression. Psychiatrists at Rush University Medical Center were among the first to test t
6 Vote(s)
6 Vote(s)
Comments Off
August 12, 2009
Predicting who will respond to a particular treatment for depression
by Michael D. Anestis, M.S. Recently, I wrote an article in which I described the evidence that variations of cognitive-behavioral therapy and interpersonal psychotherapy perform as well as or better than antidepressant medication in the treatment of depression. In the...
13 Vote(s)
13 Vote(s)
Comments Off
June 16, 2009
FDA Warnings Led To Unintended Changes In Depression Diagnosis, New Report Finds (Science Daily)
Government warnings about suicidality among children taking antidepressants appear to be associated with unintended and persistent changes in the diagnosis and treatment of depression in children and adults, according to a new report.
11 Vote(s)
11 Vote(s)
Comments Off
May 13, 2009
Role of Acupuncture in the Treatment of Depression
Acupuncture is being integrated into Western medicine, particularly for treatment of pain, nausea, asthma, and neurological conditions. Although the exact mechanism of action for acupuncture is unknown, it is associated with an increase in the level of neurobiologically active substances, such as endorphins and enkephalins. There are also data indicating that acupuncture induces the release of no
11 Vote(s)
11 Vote(s)
Comments Off
May 7, 2009
Maintaining Treatment of Depression in Adolescents Increases Remissions
A new study shows that the rate of remission in adolescents treated for depression for 36 weeks was more than double that of adolescents treated for 12 weeks, whether treatment was with an antidepressant, cognitive-behavioral therapy, or a comÂbination of both.1
11 Vote(s)
11 Vote(s)
Comments Off